跳至主要内容
临床试验/NCT03432858
NCT03432858已完成4 期

Endoscopic Carpal Tunnel Release, Infection Incidence, and Prophylactic Antibiotics: Indicated or Kick the Habit?

WellSpan Health1 个研究点 分布在 1 个国家目标入组 184 人开始时间: 2018年5月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
184
试验地点
1
主要终点
Number of Participants With Surgical Site Infection

研究概览

简要总结

This is a clinical trial to determine how effective antibiotics administered prior to endoscopic carpal tunnel release surgery are in preventing surgical site infections.

详细描述

Study participants will be randomized to a prophylactic IV antibiotic treatment arm (Vancomycin or Cefazolin) or a placebo IV saline solution. Subjects will be monitored following surgery for surgical site infections.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

盲法说明

Principal investigator, co-investigators, and participants are blinded to study intervention

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • High probability (>12 points) on the Carpal Tunnel-6 diagnostic aide
  • Recommendation for carpal tunnel release
  • Capable of providing informed consent/LAR to act on subject's behalf

排除标准

  • Patients allergic to both penicillin/cephalosporins and vancomycin
  • Patient immobilized with splint or cast
  • Unwilling unable to provide informed consent
  • Children under the age of 18

研究组 & 干预措施

Vancomycin

Active Comparator

干预措施: Vancomycin (Drug)

Cefazolin

Active Comparator

干预措施: Cefazolin (Drug)

Saline

Placebo Comparator

干预措施: Saline Solution (Drug)

结局指标

主要结局

Number of Participants With Surgical Site Infection

时间窗: 6 weeks post-operative

Definitive diagnosis of infection of surgical site -Definitive diagnosis of infection of surgical site -wounds determined to be infected will be divided into superficial or deep infections and treated according to the standard of care at WellSpan health.

次要结局

  • Number of Participants With Diabetes Diagnosis and Surgical Site Infection(6 weeks post-operative)
  • Number of Participants With Anemia Diagnosis and Surgical Site Infection(6 weeks post-operative)
  • Number of Participants With Surgical Site Infection and a History of Arthroplasty(2 weeks post-operative)
  • Number of Participants With Surgical Site Infection and History of Arthroplasty(6 weeks post-operative)
  • Number of Participants With Valvular Disease Diagnosis and Surgical Site Infection(6 weeks post-operative)
  • Number of Participants With Surgical Site Infections That Use Tobacco(6 weeks post-operative)
  • Number of Participants With Chronic Obstructive Pulmonary Disease Diagnosis and Surgical Site Infection(6 weeks post-operative)
  • Number of Participants With Peripheral Artery Disease Diagnosis and Surgical Site Infection(6 weeks post-operative)
  • Number of Participants With Surgical Site Infection That Underwent Single Incision Endoscopic Carpal Tunnel Release(6 weeks post-operative)
  • Number of Participants With Surgical Site Infection That Underwent Double Incision Endoscopic Carpal Tunnel Release(6 weeks post-operative)
  • Time From Last Cortisone Injection(6 weeks post-operative)
  • Acuity of Carpal Tunnel Syndrome(6 weeks post-operative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Richard C Trevino, MD

Orthopedic Surgeon -WellSpan Orthopedics

WellSpan Health

研究点 (1)

Loading locations...

相似试验